Skip to main content
. Author manuscript; available in PMC: 2010 Feb 22.
Published in final edited form as: Histopathology. 2006 Dec;49(6):622–633. doi: 10.1111/j.1365-2559.2006.02556.x

Table 4.

Survivin expression in human colorectal and breast adenocarcinoma tissues

Neoplastic tissue type (no. tested) Specific staining
Colorectal carcinoma Tumour cells (< 5%), nuclear
Colorectal carcinoma Tumour cells (< 5%), nuclear
Colorectal carcinoma Tumour cells (40%), nuclear
Colorectal carcinoma Tumour cells (5%), nuclear
Colorectal carcinoma Tumour cells (10%), nuclear
Colorectal carcinoma Tumour cells (< 5%), nuclear
Colorectal carcinoma Tumour cells (< 5%), nuclear
Colorectal carcinoma Tumour cells (40%), nuclear
Colorectal carcinoma Tumour cells (30%), nuclear
Colorectal carcinoma Tumour cells (< 5%), nuclear
Colorectal carcinoma Tumour cells (20%), nuclear
Breast carcinoma 0
Breast carcinoma 0
Breast carcinoma Tumour cells (< 5%), nuclear
Breast carcinoma Tumour cells (< 5%), nuclear
Breast carcinoma Tumour cells (< 5%), nuclear
Breast carcinoma Tumour cells (< 5%), nuclear
Breast carcinoma Tumour cells (< 5%), nuclear
Breast carcinoma Tumour cells (10%), nuclear
Breast carcinoma Tumour cells (10%), nuclear
Breast carcinoma Tumour cells (10%), nuclear
Breast carcinoma Tumour cells (< 5%), nuclear
Breast carcinoma Tumour cells (30%), nuclear
Breast carcinoma Tumour cells (5%), nuclear
Breast carcinoma Tumour cells (30%), nuclear